Pharmaceuticals
Alternative labels
Medication
Pharmaceutical industry
Report
Planning and governance of COVID-19 procurements to increase the National Medical Stockpile
This audit examined whether the COVID-19 National Medical Stockpile (NMS) procurement requirement was met through effective planning and governance arrangements.
Report
Patient power: unleashing choice over routine medications
This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about their medication, where doctors do not have the time or...
Report
Rationalising regulation: helping the economy recover from the corona crisis
Australia’s anachronistic, inconsistent and excessive regulatory landscape is an area of immense potential for growth-enhancing economic reforms. This paper considers regulations across a wide range of sectors, including the construction, agricultural, pharmaceutical, retail trade, mining, hospitality and tourism, and childcare sectors.
Report
Biodata and biotechnology: opportunity and challenges for Australia
This report canvasses the extraordinary recent developments in genome sequencing and genetic engineering, which will transform all biological enterprises, including healthcare, among the most important parts of the global economy. It argues that there is a opportunity for Australia to play a leading role in a major economic and revolution with digital deliverables, capitalising on...
Fact sheet
Fact Check Fact File: The history of vaccines, from smallpox to SARS and beyond
With the world focused on a fast-tracked treatment for the novel coronavirus, RMIT ABC Fact Check takes a look at the history of vaccine development in the fight against some of the world's most infectious diseases.